Detalles de la búsqueda
1.
Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie.
Clin Exp Rheumatol
; 42(3): 642-650, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37976120
2.
Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational study.
Clin Exp Rheumatol
; 41(7): 1463-1472, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36622132
3.
The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with age.
Clin Exp Rheumatol
; 40(9): 1657-1665, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34874836
4.
Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care.
Clin Exp Rheumatol
; 40(3): 551-559, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34001304
5.
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study).
Rheumatology (Oxford)
; 60(11): 5318-5328, 2021 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33738492
6.
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis.
Clin Exp Rheumatol
; 39(2): 319-328, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32662413
7.
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.
Ann Rheum Dis
; 78(6): 754-760, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30902820
8.
Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI).
Clin Exp Rheumatol
; 37(6): 937-945, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31025930
9.
[Rheumatism and gastroenterology]. / Rheuma und Gastroenterologie.
Orthopade
; 48(11): 936-941, 2019 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-31686154
10.
Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting.
Eur Radiol
; 27(9): 3662-3668, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28116513
11.
Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study.
Ann Rheum Dis
; 75(2): 408-12, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26248638
12.
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
Lancet
; 382(9906): 1705-13, 2013 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24035250
13.
German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
Rheumatol Int
; 34(1): 1-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23942828
14.
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study.
Adv Ther
; 41(1): 315-330, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950790
15.
The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapy.
Ann Rheum Dis
; 72(7): 1163-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22956596
16.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Ann Rheum Dis
; 72(6): 863-9, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22730366
17.
Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging.
Eur Radiol
; 23(7): 1773-84, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23494493
18.
Evaluation of the novel ultrasound score for large joints in psoriatic arthritis and ankylosing spondylitis: six month experience in daily clinical practice.
BMC Musculoskelet Disord
; 14: 358, 2013 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24351026
19.
The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study.
J Rheumatol
; 50(2): 185-191, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35914790
20.
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial.
RMD Open
; 9(4)2023 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114198